Skip to content

Hemi-diaphragmatic Paresis After Erector Spinae Plane Block

Hemi-diaphragmatic Paresis After Ultrasound-guided Erector Spinae Plane Block in Carotid Endarterectomy

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04706780
Enrollment
7
Registered
2021-01-13
Start date
2021-01-20
Completion date
2021-07-07
Last updated
2021-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carotid Endarterectomy, Regional Anesthesia

Keywords

Regional anesthesia, Erector spinae plane block, Carotid endarterectomy, Ultrasound guidance

Brief summary

To assess the incidence of hemi-diaphragmatic paresis following ultrasound-guided erector spinae plane (ESP) block

Detailed description

The ultrasound (USG) guided ESP block was first defined in 2016. With the administration of local anesthesia between the transverse process of the vertebra and the erector spinae muscle, it is stated that the effect mechanism of ESP is that spread blocks the ventral and dorsal rami to the paravertebral area. The aim of the study is to assess the incidence of hemi-diaphragmatic paresis following ultrasound-guided erector spinae plane block.

Interventions

OTHERESP block

ESP block performed using ultrasound guidance. Diaphragmatic excursion was measured using M-mode ultrasound during normal breathing, deep breathing and with the sniff manoeuvre.

Sponsors

Antalya Training and Research Hospital
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* 18 - 85 years * American Society of Anesthesiology (ASA) I-III * elective carotid endarterectomy

Exclusion criteria

* patient's refusal * under 18 years of age or over 65 years of age * ASA IV and above * known allergy to local anaesthetic drugs * the block cannot be applied due to bleeding disorders or localized skin infection at the injection site * history of neurological and/or neuromucular disease * history of severe bronchopulmonary disease * a moderate to severe decrease in preoperative pulmonary function, or abnormality in preoperative chest radiography data (pleural effusion, pneumothorax, or hemidiaphragm elevation) * emergency surgery

Design outcomes

Primary

MeasureTime frameDescription
incidence of hemi-diaphragmatic paresis30 minutesDiaphragmatic excursion was measured using M-mode ultrasound during normal breathing, deep breathing and with the sniff manoeuvre.

Secondary

MeasureTime frameDescription
opioid consumption1 hourintraoperative opioid consumption will be recorded
postoperative analgesia consumption24 hourspostoperative analgesia consumption for 24 hours will be recorded
intraoperative local anesthetic consumption1 houramount of intraoperative additional local anesthetic consumption will be recorded
Postoperative Numeric Rating Scale (NRS) score24 hourspostoperative pain assessment will be recorded using NRS score (NRS 0=no pain, NRS 10= most severe possible)

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026